OBJECTIVE: The purpose of this investigation was to evaluate the effects of clozapine and risperidone on spatial working memory in patients with schizophrenia. METHOD:Spatial working memory performance was evaluated at baseline and after 17 and 29 weeks in 97 patients with schizophrenia participating in a multisite trial. RESULTS: Compared with baseline performance while receiving conventional antipsychotic medication, risperidone improved, and clozapine worsened, spatial working memory performance. CONCLUSIONS: The differential effects of these medications on spatial working memory may be due to the anticholinergic effects of clozapine and prefrontal dopamine-enhancing effects of risperidone.
RCT Entities:
OBJECTIVE: The purpose of this investigation was to evaluate the effects of clozapine and risperidone on spatial working memory in patients with schizophrenia. METHOD: Spatial working memory performance was evaluated at baseline and after 17 and 29 weeks in 97 patients with schizophrenia participating in a multisite trial. RESULTS: Compared with baseline performance while receiving conventional antipsychotic medication, risperidone improved, and clozapine worsened, spatial working memory performance. CONCLUSIONS: The differential effects of these medications on spatial working memory may be due to the anticholinergic effects of clozapine and prefrontal dopamine-enhancing effects of risperidone.
Authors: Raquel E Gur; Monica E Calkins; Ruben C Gur; William P Horan; Keith H Nuechterlein; Larry J Seidman; William S Stone Journal: Schizophr Bull Date: 2006-11-13 Impact factor: 9.306
Authors: Rebecca L Fuller; Steven J Luck; Elsie L Braun; Benjamin M Robinson; Robert P McMahon; James M Gold Journal: Neuropsychology Date: 2009-01 Impact factor: 3.295
Authors: Michael G Aman; Jill A Hollway; Christopher J McDougle; Lawrence Scahill; Elaine Tierney; James T McCracken; L Eugene Arnold; Benedetto Vitiello; Louise Ritz; Allison Gavaletz; Pegeen Cronin; Naomi Swiezy; Courtney Wheeler; Kathleen Koenig; Jaswinder K Ghuman; David J Posey Journal: J Child Adolesc Psychopharmacol Date: 2008-06 Impact factor: 2.576
Authors: Margret S H Harris; Courtney L Wiseman; James L Reilly; Matcheri S Keshavan; John A Sweeney Journal: Neuropsychopharmacology Date: 2008-06-04 Impact factor: 7.853
Authors: Vera Bubenikova-Valesova; Ales Stuchlik; Jan Svoboda; Jan Bures; Karel Vales Journal: Proc Natl Acad Sci U S A Date: 2008-01-14 Impact factor: 11.205